SEMA3B is associated with disease activity and infliximab response in IBD patients but does not contribute to the development of intestinal inflammation in vivo
Laura Arosa(Instituto de Investigación Sanitaria de Santiago), Javier Conde-Aranda(Instituto de Investigación Sanitaria de Santiago)
Cited by 0
Related Papers
No related papers found
Powered by citation graph analysis